Pharmaceuticals Sector Enterprises ICT Investment Trends and Future Outlook by Segments Hardware, Software, IT Services and Network and Communications

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

According to GlobalData’s Information & Communication Technology (ICT) customer insight survey, a majority of enterprises in the pharmaceuticals sector will see their ICT budgets increase slightly in 2022 compared to 2021. The survey reveals that most enterprises see a slight increase in ICT budgets for internal ICT departments and business functions in 2022 over 2021.

The pharmaceuticals sector enterprises ICT investment trends research report provides a thorough analysis of pharmaceuticals sector enterprises ICT investment trends and how it has changed this year compared to the previous year. It also offers an easily digestible market assessment for decision-makers built around research gathered from the local IT decision-makers, which enables executives to quickly get up to speed with the current and emerging trends in pharmaceuticals sector enterprises ICT investment priorities.

Pharmaceuticals Sector Enterprises ICT Investment Budget Allocations Dynamics

GlobalData’s ICT decision-makers survey reveals a positive outlook for enterprise ICT spending in the pharmaceuticals sector, with a majority claiming that there has been a slight increase in their enterprise ICT budget for 2022 compared to 2021. With the rising popularity of generic drugs and the extinction of patents, pharmaceutical companies are increasingly focusing on R&D activities to develop innovative molecules derived from biotechnology and tailored as per a patient’s health needs.

ICT plays a key role in creating databases to direct R&D activities and clinical trials without relying on traditional trial and error methods. Further, ICT technologies enable scientists to collaborate in multiple fields such as biology and informatics. Consistent with the increase in the overall enterprise ICT budget for 2022, GlobalData’s survey suggests that there has been a considerable growth in enterprise budgets for both new ICT projects as well as for the maintenance of existing ICT systems and applications.

Pharmaceuticals Sector Enterprises ICT Investment Budget Allocation Segmentation by ICT products/services

The key ICT products or services in the pharmaceuticals sector enterprises ICT budget allocations are internal costs, hardware, software, network & communications, ICT services, consulting, and others. GlobalData’s survey findings suggest that the enterprise ICT budget allocations for most ICT product/service areas in the pharmaceuticals sector have increased in 2022 compared to 2021.

Pharmaceuticals Sector Enterprises ICT Investment Budget Allocation Segmentation by Business Functions

The key business function in the pharmaceuticals sector enterprise ICT budget allocations are procurement & operations, human resources & legal, finance & accounting, sales, marketing, & consumer relations, and research & development. GlobalData’s survey findings suggest that the enterprise ICT budget allocations for most business functions in the pharmaceuticals sector have increased in 2022 compared to 2021.

Pharmaceuticals Sector Enterprises Cloud & Digital Transformation Segmentation by Implementation Models

The key implementation models for pharmaceuticals sector enterprise cloud & digital transformation are public cloud, private cloud, hybrid cloud, cloud services, and cloud management platforms.

Pharmaceuticals Sector Enterprises Public Cloud Budget Allocation Segmentation By Service Type

The key types of services in the pharmaceuticals sector public cloud market are IaaS, PaaS, and SaaS. Most enterprises in see their public cloud computing budget allocations increase slightly for all the service types in 2022 compared to 2021.

Pharmaceuticals Sector Enterprises ICT Budget Allocations Segmentation By Segments

The key categories in pharmaceuticals sector enterprise budget allocations are hardware budget allocations, software budget allocations, managed IT services budget allocations, ICT consulting services budget allocations, network & communication budget allocations, and private mobile networks (LTE/5G) budget allocations.

Pharmaceuticals Sector Enterprises Hardware Budget Allocations Segmentation By Category

The key categories in the pharmaceuticals sector enterprise hardware budget allocations are network equipment, security equipment, servers, storage, desktop services & user support, communication devices, and others. According to GlobalData’s survey, enterprise budget allocations across most hardware categories have witnessed moderate increases in 2022 compared with 2021.

For more insights on Pharmaceuticals Sector Enterprises ICT Investment Trends, download a free report sample

Pharmaceuticals Sector Enterprises ICT Investment Trends Report Overview

Key Products/Services Internal Costs, Hardware, Software, Network & Communications, ICT Services, Consulting, and Others
Key Business Functions Procurement & Operations, Human Resources & Legal, Finance & Accounting, Sales, Marketing, & Consumer Relations, and Research & Development
Key Models Public Cloud, Private Cloud, Hybrid Cloud, Cloud Services, and Cloud Management Platforms
Key Public Cloud Models Iaas, Paas, and Saas
Key Segments Hardware Budget Allocations, Software Budget Allocations, Managed IT Services Budget Allocations, ICT Consulting Services Budget Allocations, Network & Communication Budget Allocations, and Private Mobile Networks (LTE/5G) Budget Allocations
Key Hardware Segments Network Equipment, Security Equipment, Servers, Storage, Desktop Services & User Support, Communication Devices, and Others

Scope 

  • According to GlobalData’s Information & Communication Technology (ICT) customer insight survey, a majority of enterprises in the pharmaceuticals sector will see their ICT budgets increase slightly in 2022 compared to 2021.
  • Digital transformation leveraging disruptive technologies like edge computing, IoT, AI, and ML is an ICT investment priority for enterprises in the pharmaceuticals sector in 2022.
  • Most enterprises seem to have a slight increase in their software budget allocations across all software categories in 2022 compared to 2021, while for security and data management and analytics a notable proportion witnessed a significant increase.
  • Content-filtering and anti-spam will remain a popular security hardware investment area in the next two years, while data protection/security will be a popular security software investment area in the next two years.

Reasons to Buy

  • The report is based on GlobalData’s IT Customer Insight Survey carried out annually covering key ICT decision-makers from enterprises across various industry verticals to understand their ICT investment priorities and trends.
  • This survey report offers a thorough analysis of Enterprise ICT Investment Trends and how it has changed this year compared to the previous year.
  • The report also presents an analysis of enterprise ICT budget allocations by various spending areas, business functions, and product/service categories and how they have changed this year compared to previous years.
  • With more than 50 charts the report is designed for an executive-level audience, boasting presentation quality.
  • The report provides insights in a concise format to help executives build proactive and profitable growth strategies.
  • The report provides an easily digestible market assessment for decision-makers built around research gathered from the local IT decision makers, which enables executives to quickly get up to speed with the current and emerging trends in enterprise ICT investment priorities.

Table of Contents

Table of Contents

Executive Summary

Key Findings

Survey Demographics

Enterprise ICT Budget Allocations – 2022 vs 2021

Key Business Areas and Business Challenges – 2022 vs 2021

Cloud & Digital Transformation Budget – 2022 vs. 2021

Segment ICT Budget Allocation – 2022 vs 2021

Future Outlook Enterprise Technology Priorities

Appendix

Frequently asked questions

Pharmaceuticals Sector Enterprises ICT Investment Trends and Future Outlook by Segments Hardware, Software, IT Services and Network and Communications standard reports
Currency USD
$2,995

Can be used by individual purchaser only

$8,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Pharmaceuticals Sector Enterprises ICT Investment Trends and Future Outlook by Segments Hardware, Software, IT Services and Network and Communications was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more ICT reports
Technology
New
Misinformation - Thematic Intelligence
$1,950 | April 2024
Technology
New
Accenture Plc Partner Ecosystem Profile
$250 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Pharmaceuticals Sector Enterprises ICT Investment Trends and Future Outlook by Segments Hardware, Software, IT Services and Network and Communications in real time.

  • Access a live Pharmaceuticals Sector Enterprises ICT Investment Trends and Future Outlook by Segments Hardware, Software, IT Services and Network and Communications dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.